Otofonix Encore Expert Review

The Otofonix Encore is a budget-priced prescription behind-the-ear hearing aid that earned a D grade with a SoundScore of 1.8/5 in our lab testing. Released in 2018, this device ranks #30 of 36 prescription hearing aids tested, placing it in the bottom tier of its category.

In our standardized testing, the Encore demonstrated one genuine strength: excellent feedback handling at 4.7/5, which is on par with the category average. This means the device maintains stability without whistling during typical head movements and adjustments. However, other performance areas showed significant limitations.

Speech understanding in noisy environments scored -0.8/5, falling 2.35 points below the category average—a substantial gap that may affect comprehension in challenging listening situations like restaurants or group conversations. Own-voice comfort and music streaming both scored at the low end of our scale, with own-voice at 0.1/5 and streaming at 0.0/5, each trailing the category average by more than 2.6 points.

At $295, the Encore sits in the budget prescription tier. However, shoppers in this price range may want to consider alternatives: the RxEars Rxi achieves a 3.76/5 SoundScore, and the MDHearing Volt scores 3.11/5, both offering meaningfully stronger performance. The Otofonix Encore may appeal to those prioritizing feedback-free operation above other sound quality factors, but its overall performance limitations are difficult to overlook given available alternatives.